| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 04/08/2010 | US20100086572 Rational ppi dosage forms |
| 04/08/2010 | US20100086559 Polypeptide formulation |
| 04/08/2010 | US20100086496 Oral care package |
| 04/08/2010 | US20100086495 Compositions and methods for enhancing transmucosal delivery |
| 04/08/2010 | US20100086493 Pure chlorine dioxide solution, and gel-like composition and foaming composition each comprising the same |
| 04/08/2010 | US20100086490 Gas-filled microvesicles with targeting ligand or therapeutic agent |
| 04/08/2010 | DE69514212C5 Übertragungssystem für untertitel Transmission system for subtitles |
| 04/08/2010 | DE102008050415A1 Release system, useful for cleaning textiles or administration of cosmetic or pharmaceutical active ingredients, comprises capsules exhibiting a hydrophobic and oil-soluble capsule shell and a capsule content, in an oil-in-water emulsion |
| 04/08/2010 | CA2778604A1 Active agent loaded uniform, rigid, spherical, nanoporous calcium phosphate particles and methods of making and using the same |
| 04/08/2010 | CA2739499A1 Improved nanoparticulate compositions of poorly soluble compounds |
| 04/08/2010 | CA2739181A1 Implantable device for the delivery of risperidone and methods of use thereof |
| 04/08/2010 | CA2739180A1 Implantable device for the delivery of octreotide and methods of use thereof |
| 04/08/2010 | CA2739179A1 Implantable device for the delivery of histrelin and methods of use thereof |
| 04/08/2010 | CA2739178A1 Long term drug delivery devices with polyurethane-based polymers and their manufacture |
| 04/08/2010 | CA2739018A1 Alcohol-resistant sustained-release oral pharmaceutical form based on microgranules |
| 04/08/2010 | CA2738912A1 Pharmaceutical composition for oral administration |
| 04/08/2010 | CA2738622A1 Compositions and methods for treatment of radiation exposure |
| 04/08/2010 | CA2738449A1 Novel ezetimibe formulations |
| 04/08/2010 | CA2738114A1 Compositions exhibiting delayed transit through the gastrointestinal tract |
| 04/08/2010 | CA2737399A1 Inhalable particles comprising tiotropium |
| 04/08/2010 | CA2737395A1 New controlled release active agent carrier |
| 04/08/2010 | CA2737263A1 Mucomimetic compositions and uses therefore |
| 04/08/2010 | CA2733265A1 Transdermal extended-delivery donepezil compositions and methods for using the same |
| 04/08/2010 | CA2704448A1 Amorphous compositions of sunitinib base and l-malic acid |
| 04/07/2010 | EP2172474A1 Novel peptide and pharmaceutical use of the same |
| 04/07/2010 | EP2172226A1 Method of fixing and expressing physiologically active substance |
| 04/07/2010 | EP2172225A1 Sealmess capsule |
| 04/07/2010 | EP2172224A1 Aqueous composition |
| 04/07/2010 | EP2172223A1 Composition containing physiologically active substance |
| 04/07/2010 | EP2172205A1 Pharmaceutical Formulation Comprising Lanthanum Compounds |
| 04/07/2010 | EP2172202A1 Prostaglandin derivative-containing aqueous liquid agent |
| 04/07/2010 | EP2172200A1 Coated preparation |
| 04/07/2010 | EP2172199A1 Sustained release tablet comprising pramipexole |
| 04/07/2010 | EP2172196A1 Composition containing coenzyme q10 |
| 04/07/2010 | EP2172194A1 Transdermal drug delivery system for liquid active ingredient |
| 04/07/2010 | EP2172193A1 Improved nanoparticulate compositions of poorly soluble compounds |
| 04/07/2010 | EP2172192A1 Dosage form with a core tablet of active ingredient sheathed in a compressed annular body of powder of granular material, and process and tooling for producing it |
| 04/07/2010 | EP2172191A1 Lipid pellets with enhanced taste-masking |
| 04/07/2010 | EP2172190A1 Inhalable particles comprising tiotropium |
| 04/07/2010 | EP2172189A1 Pharmaceutical Compositions |
| 04/07/2010 | EP2172106A1 Allantoin-containing skin cream |
| 04/07/2010 | EP2171706A1 Method for marking materials |
| 04/07/2010 | EP2171095A1 Mixed micelles including amphipathic conjugates of rna agents, and uses thereof |
| 04/07/2010 | EP2170708A2 Ophthalmic solutions |
| 04/07/2010 | EP2170419A1 Temporal release of growth factors from 3d micro rod scaffolds for tissue regeneration |
| 04/07/2010 | EP2170400A1 Pharmaceutical liquid composition of botulinum toxin with improved stability |
| 04/07/2010 | EP2170399A1 Intranasal administration of asenapine and pharmaceutical compositions therefor |
| 04/07/2010 | EP2170388A1 Antibody formulations |
| 04/07/2010 | EP2170368A1 Liquid protein formulations comprising gdf-5 for use at elevated temperatures |
| 04/07/2010 | EP2170348A2 Effervescent tablets for inhalatory use |
| 04/07/2010 | EP2170347A1 Single-phase pharmaceutical composite preparation (dienogest and ethinyl estradiol) for oral therapy for regulation of blood pressure |
| 04/07/2010 | EP2170333A2 Ranolazine for elevated brain-type natriuretic peptide |
| 04/07/2010 | EP2170332A1 A medicament for treating glaucoma comprising as an active ingredient cyclodextrin-clathrate compound of cilostazol |
| 04/07/2010 | EP2170319A2 Solubilized formulation of docetaxel without tween 80 |
| 04/07/2010 | EP2170310A2 Quick dissolve compositions of memantine hydrochloride |
| 04/07/2010 | EP2170305A1 Transdermal delivery system comprising glycopyrrolate to treat sialorrhea |
| 04/07/2010 | EP2170304A1 A bioerodible patch |
| 04/07/2010 | EP2170303A1 Laser marked dosage forms |
| 04/07/2010 | EP2170302A1 Sustained release bionanocomposites, a process for producing the same and use thereof |
| 04/07/2010 | EP2170300A2 Microspheres having core/shell structure |
| 04/07/2010 | EP2170299A1 A novel powder and its method of manufacture |
| 04/07/2010 | EP2170297A2 Duloxetine formulation |
| 04/07/2010 | EP2170296A2 Process for the preparation of a medicament comprising vardenafil hydrochloride trihydrate |
| 04/07/2010 | EP2170295A1 Improved pharmaceutical composition containing dihydropyridine calcium channel antagonist and method for the preparation thereof |
| 04/07/2010 | EP2170294A1 Improved pharmaceutical formulation containing an hmg-coa reductase inhibitor and method for the preparation thereof |
| 04/07/2010 | EP2170293A2 Combination formulations comprising darunavir and etravirine |
| 04/07/2010 | EP2170292A2 Tableted compositions containing atazanavir |
| 04/07/2010 | EP2170291A1 Pharmaceutical composition containing acetylcholine esterase inhibitor and method for the preparation thereof |
| 04/07/2010 | EP2170290A1 System for controlled release of an active principle and method for preparation |
| 04/07/2010 | EP2170289A2 Preparation method for solid disupersions |
| 04/07/2010 | EP2170288A2 Pellets containing a pharmaceutical substance, method for the production thereof and use of the same |
| 04/07/2010 | EP2170286A1 Preparation of fine particles |
| 04/07/2010 | EP2170285A2 Process for the preparation of controlled-release solid formulations containing oxcarbazepine, and formulations obtainable by said process |
| 04/07/2010 | EP2170284A2 A method of preparing a pharmaceutical co-crystal composition |
| 04/07/2010 | EP2170283A1 Formation of stable submicron peptide or protein particles by thin film freezing |
| 04/07/2010 | EP2170282A2 Method for preparing rapidly disintegrating formulation for oral administration and apparatus for preparing and packing the same |
| 04/07/2010 | EP2170281A1 Method for the production of a medicament containing tadalafil |
| 04/07/2010 | EP2170280A2 An inhalable composition comprising nicotine |
| 04/07/2010 | EP2170279A1 Methods for producing aripiprazole suspension and freeze-dried formulation |
| 04/07/2010 | EP2170278A2 Formulations of n-(2-acetyl-4,6-dimethylphenyl)-3-{ý(3,4 dimethyl-5-isoxazolyl)amino]sulfonyl}-2-thiophenecarboxamide |
| 04/07/2010 | EP2170277A1 Chemical modification of maleated fatty acids |
| 04/07/2010 | EP2170276A1 Intravaginal drug delivery devices for the delivery of macromolecules and water-soluble drugs |
| 04/07/2010 | EP2170275A2 Dual portion lozenge dosage form |
| 04/07/2010 | EP2170274A1 Compositions, articles and methods comprising tspo ligands for preventing or reducing tobacco-associated damage |
| 04/07/2010 | EP2170273A2 Pharmaceutical formulation for the production of rapidly disintegrating tablets |
| 04/07/2010 | EP2170272A1 Improved taste-masking extrudates |
| 04/07/2010 | EP2170271A2 Locally administrated low doses of corticosteroids |
| 04/07/2010 | EP2170270A2 Compositions for delivering medicaments into the lungs, uses thereof |
| 04/07/2010 | EP2170269A1 Article comprising calcium for reducing the production of tsst-1 |
| 04/07/2010 | EP2170268A2 Compositions of specific binding agents to hepatocyte growth factor |
| 04/07/2010 | EP2170267A1 Cationic peptide for delivering an agent into a cell |
| 04/07/2010 | EP2170233A2 Methods and products for improving wound healing |
| 04/07/2010 | EP1845983B1 Ophthalmic compositions and methods of using the same |
| 04/07/2010 | EP1830818B1 Process for the manufacture of sterile suspensions or lyophilisates of low-soluble basic peptide complexes, pharmaceutical formulations comprising these complexes and their use as medicament |
| 04/07/2010 | EP1809258B1 Dosage forms having a microreliefed surface and methods and apparatus for their production |
| 04/07/2010 | EP1781265B1 Pharmaceutical formulations of potassium atp channel openers and uses thereof |
| 04/07/2010 | EP1589973B1 Formulation and methods for the treatment of thrombocythemia |
| 04/07/2010 | EP1583559B1 Compositions for prevention and treatment of cold and influenza-like symptoms comprising select mucoadhesive polymers |
| 04/07/2010 | EP1423150B1 Sustained release of microcrystalline peptide suspensions |
| 04/07/2010 | EP1313448B1 Topical aminolevulinic acid-photodynamic therapy for acne vulgaris |